EGFR and neoplasm: EMT also contributes to tumor invasion, proliferation, metastasis, and therapy resistance to EGFR‐TKIs.15, 16 As a consequence, targeting EMT might be a potential strategy to reverse or prevent EGFR‐TKIs resistance.